Journal News

Host fatty acids enhance dengue virus infectivity

Emily Ulrich
June 12, 2025

Mosquito-borne flavivirus infections cause changes in host lipid metabolism. For example, scientists found that the dengue virus, which has no known antiviral treatments, recruits host fatty acid synthase to aid in viral replication. In a recent Journal of Biological Chemistry article, Julia Hehner at Philipps University Marburg and a team in Germany investigated the reliance of various flaviviruses on host fatty acid elongases and desaturases, key enzymes in the biosynthesis of monounsaturated and polyunsaturated fatty acids.

National Institute of Allergy and Infectious Diseases 3D renderings of dengue virions
National Institute of Allergy and Infectious Diseases
3D renderings of dengue virions

Working with a human hepatic cell line, the authors used RNA interference to individually knock down each fatty acid elongase and desaturase, enzymes that catalyze specific steps for producing fatty acids of different lengths. They exposed the cell lines to dengue, Zika, West Nile, yellow fever and tick-borne encephalitis viruses to measure viral replication. Only dengue virus showed sensitivity to the knockdowns, indicating that this virus relies on fatty acids of specific lengths, while the other viruses can compensate for the loss of one enzyme. Knocking down either the ultra-long-chain elongase ELOVL4 or desaturase FADS2 caused decreased dengue viral titers.

The researchers determined that ELOVL4 knockdown led to slightly lower viral protein levels in the infected cells, possibly signaling ELOVL4 involvement in delaying RNA replication. Surprisingly, the cells lacking FADS2 showed a slight increase in viral protein levels. The authors next measured plaque formation of dengue virus particles produced by the knockdown cell lines and found that cells lacking FADS2 produced viral particles with diminished infectivity. This indicates that FADS2 may promote lipid synthesis necessary for dengue virion assembly.

Future studies will help address the mechanisms behind the observed increase in viral protein levels upon FADS2 knockdown. Further experiments will also help researchers fill in the mechanistic details about how the ultra-long-chain fatty acids produced by ELOVL4 enhance dengue virus infectivity.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Emily Ulrich

Emily Ulrich is the ASBMB’s science editor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

AI in the lab: The power of smarter questions
Essay

AI in the lab: The power of smarter questions

Oct. 14, 2025

An assistant professor discusses AI's evolution from a buzzword to a trusted research partner. It helps streamline reviews, troubleshoot code, save time and spark ideas, but its success relies on combining AI with expertise and critical thinking.

Training AI to uncover novel antimicrobials
Feature

Training AI to uncover novel antimicrobials

Oct. 9, 2025

Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Journal News

AI-designed biomarker improves malaria diagnostics

Oct. 8, 2025

Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Journal News

Matrix metalloproteinase inhibitor reduces cancer invasion

Oct. 8, 2025

Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Journal News

Antibiotic sensor directly binds drug in resistant bacteria

Oct. 8, 2025

Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.

ApoA1 reduce atherosclerotic plaques via cell death pathway
Journal News

ApoA1 reduce atherosclerotic plaques via cell death pathway

Oct. 1, 2025

Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.